BLACKMORES BIOTIN H+

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

Panicum miliaceum, Quantity: 40 mg (Equivalent: Panicum miliaceum, Qty 400 mg); Equisetum arvense, Quantity: 50 mg (Equivalent: Equisetum arvense, Qty 500 mg); Camellia sinensis, Quantity: 50 mg (Equivalent: Camellia sinensis, Qty 300 mg; Equivalent: caffeine, Qty 2.5 mg); Ascophyllum nodosum, Quantity: 50 mg (Equivalent: Ascophyllum nodosum, Qty 500 mg; Equivalent: iodine, Qty 56 microgram); zinc sulfate monohydrate, Quantity: 41.16 mg (Equivalent: zinc, Qty 15 mg); Biotin, Quantity: 150 microgram; ascorbic acid, Quantity: 60 mg; high selenium yeast, Quantity: 58.33 mg (Equivalent: selenium, Qty 70 microgram); Capsicum frutescens, Quantity: 1.3 mg (Equivalent: Capsicum frutescens, Qty 26 mg); d-alpha-tocopheryl acid succinate, Quantity: 1.86 mg (Equivalent: d-alpha-tocopheryl acid succinate, Qty 2.25 IU); betacarotene, Quantity: 1.5 mg

Disponível em:

Blackmores Ltd

DCI (Denominação Comum Internacional):

Ascophyllum nodosum,Ascorbic acid,Betacarotene,Biotin,Camellia sinensis,Capsicum frutescens,d-alpha-Tocopheryl acid succinate,Eq

Forma farmacêutica:

Tablet, film coated

Composição:

Excipient Ingredients: ethylcellulose; magnesium stearate; colloidal anhydrous silica; maize starch; dextrates; croscarmellose sodium; microcrystalline cellulose; soy polysaccharide; hypromellose; macrogol 8000; iron oxide red; titanium dioxide; Carnauba Wax; purified water; Acacia; sodium alginate; Pea Starch

Via de administração:

Oral

Resumo do produto:

Visual Identification: Medium oval shaped pink film coated tablet; Container Type: Bottle

Status de autorização:

Licence status A

Data de autorização:

2016-08-04